CNADF (CanadaBis Capital) OCF Margin %: 13.43% (As of Oct. 2025)


What is CanadaBis Capital OCF Margin %?

CanadaBis Capital CNADF -89.50% OCF Margin % is 13.43% as of Oct. 2025. The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, CanadaBis Capital ranks worse than 84.52% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. CanadaBis Capital's Cash Flow from Operations for the three months ended in Oct. 2025 was $0.31 Mil. CanadaBis Capital's Revenue for the three months ended in Oct. 2025 was $2.33 Mil. Therefore, CanadaBis Capital's OCF Margin % for the quarter that ended in Oct. 2025 was 13.43%.

As of today, CanadaBis Capital's current OCF Yield % is -98.44%.

The historical rank and industry rank for CanadaBis Capital's OCF Margin % or its related term are showing as below:

CNADF' s OCF Margin % Range Over the Past 10 Years
Min: -81.71   Med: -10.17   Max: 24.97
Current: -13.98

During the past 10 years, the highest OCF Margin % of CanadaBis Capital was 24.97%. The lowest was -81.71%. And the median was -10.17%.

CNADF's OCF Margin % is ranked worse than
84.52% of 956 companies
in the Drug Manufacturers industry
Industry Median: 9.985 vs CNADF: -13.98

CanadaBis Capital OCF Margin % Related Terms

CanadaBis Capital OCF Margin % Historical Data

* Premium members only.

The historical data trend for CanadaBis Capital's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanadaBis Capital OCF Margin % Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.31 -0.71 24.97 -1.43 -18.91

CanadaBis Capital Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.30 16.51 -113.74 9.55 13.43

CNADF vs ZTS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanadaBis Capital OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's OCF Margin % distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's OCF Margin % falls into.


CanadaBis Capital OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

CanadaBis Capital's OCF Margin for the fiscal year that ended in Jul. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jul. 2025 )/Revenue (A: Jul. 2025 )
=-2.334/12.345
=-18.91 %

CanadaBis Capital's OCF Margin for the quarter that ended in Oct. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Oct. 2025 )/Revenue (Q: Oct. 2025 )
=0.313/2.331
=13.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 13.43% mean?
CanadaBis Capital (CNADF) has a OCF Margin % of 13.43% as of Oct. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CanadaBis Capital and its competitors. According to the industry distribution chart, CanadaBis Capital ranks #808 out of 956 companies in the Drug Manufacturers industry, placing it in the top 84.5%.
Is CanadaBis Capital's OCF Margin % too high?
CanadaBis Capital's current OCF Margin % is 13.43%. The Drug Manufacturers industry median OCF Margin % is 9.99. CanadaBis Capital's value of 13.43% is 34.5% above this industry median. Based on the distribution chart, CanadaBis Capital ranks #808 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does CanadaBis Capital's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, CanadaBis Capital ranks #808 out of 956 companies for OCF Margin %. This places CanadaBis Capital in the lower half of its industry. The industry median OCF Margin % is 9.99. CanadaBis Capital's value of 13.43% is 34.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CanadaBis Capital's current OCF Margin % of 13.43% is 34.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CanadaBis Capital and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanadaBis Capital's current OCF Margin % is 13.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (CNADF) has a current OCF Margin % of 13.43%. The current OCF Margin % is 13.43% and 34.5% above the Drug Manufacturers industry median of 9.99. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For CanadaBis Capital (CNADF), the current OCF Margin % is 13.43% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanadaBis Capital Business Description

Address 255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.